Kaiser Permanente joins phase 3 clinical trial for COVID-19 vaccine
The late-stage clinical trial will test the vaccine in 1,400 adults at 4 sites in California and Oregon.
Early colorectal cancer screening benefits African Americans
Kaiser Permanente study published in the journal Gastroenterology supports starting screening at age 45 among this higher-risk population.
Living longer and better after cancer
Clinical trials play a vital role in advancing cancer treatment at Kaiser Permanente, improving patients’ survival and quality of life.
On-demand HIV prevention pills worked well, study shows
Kaiser Permanente Northern California researchers say new as-needed PrEP regimen may increase use of the highly effective medication.
Large drop in hospitalized heart attack patients seen during COVID-19 pandemic
Kaiser Permanente research in Northern California backs anecdotal reports of people avoiding emergency care because of concerns over the coronavirus.